CYDY. I vote for continued growth. Leronlimab treats with no serious side effects. It restores balance to the immune system so that it can do it's work. I follow the research. It works. It crosses the blood-brain barrier too and treats metastasis to the brain. Breast Cancer, Pancreatic Cancer, other solid tumor cancers, Covid19 patients on ventilators, post-Covid19 patients (longhaulers), fatty liver disease, & HIV all have study data of treatment with leronlimab. Keep an eye on a better future in medicine. IMO.
With this much at stake, I certainly voted to give the company the ability to raise money to pursue treating these diseases.
(13)
(0)
CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.